ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998

Corrections Made To NCI Phone Directory

May 17, 1991

AACR Academy Names 2014 Class of Fellows

April 4, 2014

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

NIH Issues Interim Guidelines For Research Using fetal Tissue

March 26, 1993